Learn More


 
MBA Tools
MBA Glossary

 


Aegerion Pharmaceuticals, Inc. - AEGR - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

 

Aegerion Pharmaceuticals, Inc. - SIC # 8731

Ticker Exchange SIC # Website Latest Ticker
AEGR Nasdaq 8731 http://www.aegerion.com/ 62.13 Stock Down -1.57

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Aegerion Pharmaceuticals, Inc.

Isis Pharmaceuticals Making Antisense - Jun 17th, 2013 3:25 pm
Why Aegerion Is Worth 1,732 Times Sales - Jun 12th, 2013 3:00 am
This Week in Biotech - Jun 8th, 2013 10:10 am
[video] A Drug to Fight HoFH - Jun 5th, 2013 3:45 pm
CHMP Positive on Aegerion's Lojuxta - Jun 3rd, 2013 3:00 pm
Europe is Positive on these 2 Drugs - Jun 1st, 2013 5:00 pm


View All Current Headlines >>

Bookmark and Share
facebooktwitter